Baker Brothers Advisors - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 28 filers reported holding TSCAN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,129,068
+2.4%
2,784,7920.0%0.04%
+2.5%
Q2 2023$6,961,980
+19.0%
2,784,7920.0%0.04%
+25.0%
Q1 2023$5,848,063
+35.5%
2,784,7920.0%0.03%
+23.1%
Q4 2022$4,316,428
-49.2%
2,784,7920.0%0.03%
-53.6%
Q3 2022$8,494,000
-3.0%
2,784,7920.0%0.06%
+12.0%
Q2 2022$8,758,000
+119.5%
2,784,792
+95.4%
0.05%
+117.4%
Q1 2022$3,990,000
-37.8%
1,425,0000.0%0.02%
-25.8%
Q4 2021$6,413,000
-46.0%
1,425,0000.0%0.03%
-40.4%
Q3 2021$11,885,0001,425,0000.05%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DC Funds, LP 630,000$5,254,00020.63%
Deer IX & Co. Ltd. 1,245,505$9,349,0000.96%
DC Investments Management, LLC 35,563$297,0000.55%
Alphabet Inc. 1,077,080$8,983,0000.21%
Monashee Investment Management LLC 100,000$834,0000.15%
RA Capital Management 1,255,317$10,469,0000.14%
HHLR ADVISORS, LTD. 1,282,976$10,700,0000.14%
Tekla Capital Management LLC 200,000$1,668,0000.05%
Baker Brothers Advisors 1,425,000$11,885,0000.05%
CAAS CAPITAL MANAGEMENT LP 75,000$626,0000.01%
View complete list of TSCAN THERAPEUTICS INC shareholders